Project Grant R21MH138836

Award Date 3/17/25
Completion Date 2/28/27
Dollars Obligated $246K
Federal Grant Program
93.242
Assistance Type
Project Grant
Place of Performance
Virginia, USA
Similar Awards
This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), provides $2,199,102 to the University of North Carolina at Chapel Hill to conduct research on the genomic risk factors and environmental contributors to postpartum depression (PPD). The key objectives are to: 1) Expand the existing MOMgenes Fight PPD study to recruit 8,000 new samples, including a focus on Black, Indigenous, and People of Color (BIPOC)...
This federal Project Grant award of $418,178 from the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), aims to provide mechanistic insights into the neurobiological mechanisms by which maternal sensitivity is compromised by postpartum depression. Specifically, the University of Massachusetts (UMass), through its Office of Grant & Contract Administration, will use intersectional viral...
This Project Grant award from the National Institute of Child Health and Human Development (NICHD), under CFDA Program 93.865 (Child Health and Human Development Extramural Research), will provide $689,409 to the University of Illinois to conduct a clinical translational study on the role of the microbiota-gut-brain axis (MGBA) in perinatal depression (PND). The research aims to determine causal influences of MGBA signatures on depressive symptom severity during pregnancy and postpartum,...
This federal Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) will provide $729,821 to the University of Alabama at Birmingham (UAB) from February 1, 2025 to January 31, 2026. The project aims to mechanistically examine the role of nuclear long non-coding RNAs (lncRNAs) in regulating 3D chromatin organization and its functional significance in Major Depressive Disorder (MDD). Specifically, the study will...
The National Institute of Mental Health (NIMH) awarded a $2,278,274 Project Grant (CFDA 93.242 - Mental Health Research Grants) to Vanderbilt University to conduct a longitudinal investigation of neuroplasticity during pregnancy using multiple imaging modalities. The project aims to characterize changes in brain structure and function across pregnancy, examine the underlying hormonal changes, and explore the potential functional consequences of these brain changes, including their impact on...
The National Institute of Mental Health (NIMH) awarded Duke University a $1,406,795 Project Grant under the Mental Health Research Grants program (CFDA 93.242) to investigate the role of microglia-serotonin interactions in the developing brain. The research aims to determine the mechanisms by which maternal high-fat diet leads to microglial overeating and removal of serotonin neurons in male offspring, resulting in behavioral abnormalities. Specifically, the project will examine how maternal...
This $2,220,017.04 Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) will support a large-scale, single-cell characterization of the molecular and cellular networks involved in mood regulation circuitry in major depressive disorder (MDD). The project aims to: Identify transcriptomic changes associated with MDD at the single-cell level across three key brain regions - the anterior cingulate cortex,...
This Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants (CFDA 93.242) program provides $2,084,142 to the University of Virginia to develop a portable, low-cost, point-of-care microfluidic system for rapid pharmacogenomic screening of patients with major depressive disorder (MDD). The goal is to enable physicians to quickly assess a patient's metabolizer status for selective serotonin reuptake inhibitors (SSRIs) and other...
This federal Project Grant award from the National Institute of Mental Health (CFDA 93.242 - Mental Health Research Grants) to Northeastern University is providing $237,000 to investigate the role of the hormone allopregnanolone in producing long-term alterations in medial prefrontal cortex function observed in primiparous animals. The research aims to establish a causal, mechanistic link between the neurological changes that occur during pregnancy and the postpartum period. Through...
This three-year, $3.456 million project grant from the National Institute of Mental Health (NIMH) Mental Health Research Grants program (CFDA 93.242) will fund research into the role of microglia in neurodevelopmental disorders. The grantee, Cold Spring Harbor Laboratory, will merge two-photon imaging of microglia and synapses in the brains of live mice with single-cell genomics and CRISPR screens. This will help define microglia's role in experience-dependent synaptic refinement, a process...

This federal Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) provides $246,306 to the University of Virginia to investigate the relationship between postpartum depression (PPD) and microRNA (miRNA) expression patterns in neuron-derived exosomes. The study aims to 1) characterize miRNA patterns across pregnancy and into the postpartum period, and 2) compare perinatal neuron-derived exosome miRNA patterns between mood disorder groups and healthy controls. Insights from this research are expected to enhance understanding of the biological basis of PPD and provide a framework for future in vivo and longitudinal studies. The award period runs from March 17, 2025 to February 28, 2027.

Generated 4/1/25, 4:43 AM